Lilium pumilum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008762
Compound index — L
887 substances begin with L. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Lilium pumilum – Lubiprostone.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Lilium Pumilum Bulb US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008763
Lilium tigrinum CA-NHP Not yet graded
CA licensed ingredient
Market presence32 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008764
Lima Bean US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008765
Lime tree CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008766
Limnospira fusiformis EU-NOVEL Not yet graded
Not novel in food
also: J.W.G.Lund 1990; Spirulina fusiformis Woronichin 1934, Arthrospira fusiformis (Voronichin) Komárek &
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008767
Limnospira indica EU-NOVEL Not yet graded
Not novel in supplements
also: N.Jeeji Bai 1992; Arthrospira indica Desikachary &
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008768
Limnospira maxima EU-NOVEL Not yet graded
Not novel in food
also: Arthrospira maxima Setchell &; N.L.Gardner 1917, Spirulina maxima (Setchell &; N.L.Gardner) Geitler 1932, Oscillatoria pseudoplatensis Bourrelly 1970
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008769
Limnospira platensis CA-NHP Not yet graded
CA licensed ingredient
Market presence35 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008770
Limonene, (+)- US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008771
Limosilactobacillus Fermentum CA-NHPEU-NOVELUS-DRUG Not yet graded
Limosilactobacillus Reuteri CA-NHPEU-NOVELUS-DRUG Not yet graded
Limosilactobacillus vaginalis EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008774
Limulus CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008775
Limulus Polyphemus US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Blood Coagulation Factor [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008776
Linaclotide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedA06AX04; Guanylate Cyclase Activators [MoA]; Guanylate Cyclase-C Agonist [EPC]
Earliest US approval2012
Market presence13 US product listings · 4 FDA applications · 1 EU medicines
Etalyn identifierETA-C-008777
Linagliptin EU-MEDUS-DRUG Not yet graded
Linagliptin And Metformin Hydrochloride US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008779
Linalool, (+/-)- US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008780
Linaria vulgaris CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008781
Lincomycin US-DRUG Not yet graded
US: anda
Earliest US approval1964
Market presence18 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008782
Lindane US-DRUG Not yet graded
Earliest US approval1974
Market presence12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008783
Lindera aggregata CA-NHP Not yet graded
CA licensed ingredient
Market presence136 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008784
Lindera Aggregata Root US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008785
Lindernia anagallis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008786
Linerixibat EU-MEDUS-DRUG Not yet graded
EU medicine: OpinionUS: drug for further processing
Class as recordedA05AX; Ileal Bile Acid Transporter Inhibitor [EPC]; Ileal Bile Acid Transporter Inhibitors [MoA]
Earliest US approval2026
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-008787
Linezolid US-DRUG Not yet graded
US: anda
Class as recordedOxazolidinone Antibacterial [EPC]; Oxazolidinones [CS]
Earliest US approval2000
Market presence61 US product listings · 29 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008788
lingzhi CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008789
Lini semen CA-NHPEU-HERB Not yet graded
Linoleic Acid CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 1 authorised / 0 refusedCA licensed ingredientUS: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Ascorbic Acid [CS]
Market presence3 US product listings · 2 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Linoleic acid contributes to the maintenance of normal blood cholesterol levels” | Authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-008791
Linolenic Acid US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Ascorbic Acid [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008792
Linseed Oil CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008793
Linum catharticum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008794
Linum usitatissimum L. subsp. sativa CA-NHP Not yet graded
CA licensed ingredient
Market presence30 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008796
Linvoseltamab-Gcpt US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008798
Liothyronine ETALYNUS-DRUG D/insufficientband 6
US: anda
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Earliest US approval1956
Market presence121 US product listings · 12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008800
Liotrix (T4 US-DRUG Not yet graded
Earliest US approval1969
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008801
lipegfilgrastim EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL03AA14
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008803
Lipil®, containing docosahexaenoic acid (DHA) and arachidonic acid (ARA) from single cell oils EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Lipil® contributes to optimal brain development of infants and young children” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008804
Lipoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008805
liposomal EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01DB01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008806
Liposomal vitamin C EU-NOVEL Not yet graded
Not novel in food
Parts in scopeSubstance/extract/preparation
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008807
Lipoteichoic acid from Biofilm Adhesion Component of Streptococcus uberis EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008808
Lippia citrodora EU-NOVEL Not yet graded
Lippia origanoides Kunth EU-NOVEL Not yet graded
Novel, not yet authorised
also: Lippia graveolens Kunth
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008810
Lippia triphylla EU-NOVEL Not yet graded
Not novel in food
also: Lemon Verbena; Lemon Beebrush; Aloysia citrodora, Lippia citrodora
Parts in scopeNon-concentrated aqueous infusion (leaves); Leaves, flowers and essential oil
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008811
liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008812
Liquid Petroleum US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence20 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008813
Liquid Phenol 90% CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008814
Liquidambar formosana CA-NHP Not yet graded
CA licensed ingredient
Market presence51 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008815
Liquidambar orientalis CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008816
Liquidambar Styraciflua Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]
Market presence45 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008817
Liquidambar Styraciflua Resin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008818
Liquiritiae radix EU-HERB Not yet graded
Herbal monograph: D: Draft under discussion
also: Liquorice Root; Glycyrrhiza glabra L.; Glycyrrhiza inflata Bat.; Glycyrrhiza uralensis Fisch.
Class as recordedherbal: Cough and cold;Gastrointestinal disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-008819
Liraglutide EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, OpinionUS: anda
Class as recordedA10AE56; A10BJ02; GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]
Earliest US approval2010
Market presence62 US product listings · 14 FDA applications · 5 EU medicines
Etalyn identifierETA-C-008820
Liriodendron Tulipifera Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008821
Liriope Spicata Tuber US-DRUG Not yet graded
US: unapproved drug other
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008822
Lisdexamfetamine US-CSA Not yet graded
CSA Schedule II
Class as recordedDEA: stimulant
DEA other namesVyvanse
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008823
Lisdexamfetamine Dimesylate US-DRUG Not yet graded
US: anda
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
Earliest US approval2007
Market presence198 US product listings · 25 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008824
Lisinopril US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]
Earliest US approval1987
Market presence395 US product listings · 37 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008825
lisocabtagene maraleucel EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01XL08
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008826
Lisocabtagene Maraleucel Lentivirus Vector US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008827
Listeria Monocytogenes US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008828
lisuride EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008829
Litchi chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence75 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008830
Lithium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Earliest US approval1970
Market presence217 US product listings · 41 FDA applications · 1 Canadian licensed products
Etalyn identifierETA-C-008831
Lithium benzoicum CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008832
Lithium bromatum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008833
Lithium carbonicum CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008834
Lithium Fluoride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008835
Lithium Iodate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008836
Lithium muriaticum CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008837
Lithium Oxide US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008838
Lithospermum erythrorhizon CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008839
Lithothamnion calcareum f. corallioides CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008841
Lithothamnion corallioides CA-NHP Not yet graded
CA licensed ingredient
Market presence127 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008842
Lithothamnium calcareum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008843
Lithothamnium coralliodes CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008844
Litsea cubeba CA-NHPEU-NOVEL Not yet graded
Litsea Cubeba Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008846
live EU-MED Not yet graded
EU medicine: Authorised, Opinion
Class as recordedJ07AE02; J07BX04; QI06AH; QI06AX
Market presence26 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008847
Live aroA gene deleted Escherichia coli EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008848
live attenuated EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BD54; J07BH01; J07BP01
Market presence4 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008849
live attenuated Aujeszky's disease virus EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008850
live attenuated avian infectious bronchitis virus variant strain 4-91 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008851
live attenuated bovine respiratory syncytial virus (BRSV) EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008852
Live attenuated canine distemper virus strain Onderstepoort: 105.1 – 106.5 TCID50 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008853
live attenuated infectious bursal disease virus (IBDV) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008854
live attenuated Muscovy duck parvovirus EU-MED Not yet graded
EU medicine: Lapsed
Class as recordedQI01BD03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008855
live attenuated rabies virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008856
live avian infectious bronchitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008857
live Bordetella bronchiseptica bacteria strain B-C2 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008858
live deletion-mutant Streptococcus equi strain TW928 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008859
live feline calicivirus (strain F9) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008861
live feline panleucopenia virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008862
live feline viral rhinotracheitis virus (strain F2) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008863
live gE- tk- double-gene-deleted bovine herpes virus type 1 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008864
Live Lactobacillus casei strain Shirota EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Daily consumption of live Lactobacillus casei strain Shirota as present in a fermented milk product helps maintain the upper respiratory tract defences by helping to support immune functions” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008860
Live myxoma vectored RHD virus strain 009 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008865
Live myxoma vectored RHD virus strain MK1899 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008866
live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009 EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI08AD
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008867
Live non-pathogenic Escherichia coli O141:K94 (F18ac) and O8:K87 (F4ac) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008868
live non-pathogenic Escherichia coli O8:K87 EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI09AE03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008869
live recombinant EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008870
Live recombinant canine parvovirus strain 630a: 105.1 – 106.7 TCID50 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008871
Live Recombinant E2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus E2 gene (CP7_E2alf) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008872
live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rFP-LT) and avian encephalomyelitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008873
Live recombinant Marek's disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008874
Live recombinant turkey herpes virus EU-MED Not yet graded
EU medicine: Authorised
Class as recordedQI01AD16
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008875
Live recombinant turkey herpesvirus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008876
Live yoghurt cultures EU-CLAIM Not yet graded
EU claims 1 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Live cultures in yoghurt or fermented milk improve lactose digestion of the product in individuals who have difficulty digesting lactose” | Authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008877
Liver CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008878
Lixisenatide EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedA10AE54; A10BJ03; GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]
Earliest US approval2016
Market presence1 US product listings · 2 FDA applications · 2 EU medicines
Etalyn identifierETA-C-008879
LL-37 US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008880
Lobaria Pulmonaria CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedActively Acquired Immunity [PE]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence85 US product listings · 3 Canadian licensed products
Etalyn identifierETA-C-008881
Lobelia cardinalis CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008882
Lobelia Cardinalis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Cell-mediated Immunity [PE]; Cholinergic Nicotinic Agonist [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008883
Lobelia chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008884
Lobelia Erinus CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Amphenicol-class Antibacterial [EPC]; Amphenicols [EXT]; Bacterial Proteins [CS]
Market presence1 US product listings · 3 Canadian licensed products
Etalyn identifierETA-C-008885
Lobelia Inflata CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence44 US product listings · 84 Canadian licensed products
Etalyn identifierETA-C-008886
Lobelia Inflata Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence41 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008887
Lobelia syphilitica CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008888
Lobster, Unspecified US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008889
Lodoxamide Tromethamine US-DRUG Not yet graded
Earliest US approval1993
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008890
Loeselia Mexicana TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedIncreased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008891
Loeselia Mexicana Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008892
Lofexidine Hydrochloride US-DRUG Not yet graded
US: anda
Earliest US approval2018
Market presence12 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008893
lokivetmab EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008894
Lolium Multiflorum Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008895
Lolium Perenne Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence50 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008896
Lolium Perenne TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008897
Lolium Pratense Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008898
Lolium temulentum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008899
Lolium Temulentum TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008900
Lomatium dissectum CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008901
Lomatium Dissectum Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008902
Lomatium Dissectum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008903
Lomefloxacin Hydrochloride US-DRUG Not yet graded
Earliest US approval1992
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008904
Lomitapide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedC10AX12; Cytochrome P450 3A4 Inhibitors [MoA]; Microsomal Triglyceride Transfer Protein Inhibitor [EPC]; Microsomal Triglyceride Transfer Protein Inhibitors [MoA]
Earliest US approval2012
Market presence17 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-008905
Lomustine US-DRUG Not yet graded
US: anda
Class as recordedAlkylating Activity [MoA]; Alkylating Drug [EPC]
Earliest US approval1976
Market presence13 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008906
Lonafarnib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]
Earliest US approval2020
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-008907
Lonapegsomatropin EU-MEDUS-DRUG Not yet graded
Lonapegsomatropin-Tcgd US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2021
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008909
Loncastuximab Tesirine-Lpyl US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008911
Long Chain Fatty Acids (EPA/DHA) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “A diet rich in long chain fatty acids may help normal immune system function.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Long tradition of use in helping joint mobility. Renowned for helping maintain Joint Mobility and Flexibility” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008912
Long chain Omega 3 fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “-long chain Omega 3 fatty acids are important for a healthy immune system; -LC n3 PUFA help reduce inflammation.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps maintain supple and flexible joints” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008913
Long chain Omega 6 polyunsaturated fatty acid GLA ( gamma-linolenic acid) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Promotes youth and elasticity of the skin / Helps to maintain skin hydration / Contributes to women well being” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008914
Long chain omega-3 fatty acids EPA and DHA EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Long-chain omega-3 fatty acids EPA and DHA help maintain healthy levels of good cholesterol. Normal levels of good cholesterol are important for keeping your heart and blood vessels healthy. Long-chain omega-3 fatty acids EPA and DHA help maintain normal cholesterol levels.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008915
Long Pepper US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008916
Long-(arg3)insulin-Like Growth FACTOR-I US-DRUG Not yet graded
US: bulk ingredient
Class as recordedHuman Growth Hormone [CS]; Recombinant Human Growth Hormone [EPC]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008917
Long-chain Omega-3 fatty acids EPA and DHA EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Maternal Health; Pregnancy and nursing Clarification provided The omega-3 fatty acids EPA and DHA help sustain pregnancy duration. Consumption of long chain omega-3 fatty acids increases breast milk DHA levels during nursing.Consumption of long chain omega-3 fatty acids during pregnancy and nursing increases the mother's DHA stores. Maternal consumption of EPA and DHA during pregnancy may support neural and visual…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008918
Lonicera caerulea CA-NHP Not yet graded
CA licensed ingredient
Market presence22 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008919
Lonicera Canadensis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008920
Lonicera caprifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence22 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008921
Lonicera Caprifolium Flower US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Animal Fur [CS]; Antigens; Cell-mediated Immunity [PE]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008922
Lonicera Caprifolium Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008923
Lonicera Caprifolium Whole US-DRUG Not yet graded
US: otc monograph drug
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008924
Lonicera caprifolium-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008925
Lonicera Hypoglauca Flower US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008926
Lonicera japonica CA-NHP Not yet graded
CA licensed ingredient
Market presence524 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008927
Lonicera Japonica Flower US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008928
Lonicera Japonica TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008929
Lonicera macranthoides CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008930
Lonicera nigra CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008931
Lonicera xylosteum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008932
Lonicera Xylosteum Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008933
lonoctocog alfa EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008934
Loperamide Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedOpioid Agonist [EPC]; Opioid Agonists [MoA]; Skin Barrier Activity [PE]
Earliest US approval1976
Market presence254 US product listings · 48 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008935
Lophatheri gracilis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008936
Lophatherum gracile CA-NHP Not yet graded
CA licensed ingredient
Market presence244 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008937
Lophophytum leandri CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008938
Lophophytum Leandrii US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008939
Lopinavir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]
Earliest US approval2000
Market presence24 US product listings · 14 FDA applications · 2 EU medicines
Etalyn identifierETA-C-008940
Loprazolam US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-008941
Loracarbef US-DRUG Not yet graded
Earliest US approval1991
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008942
Loratadine US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
Earliest US approval1993
Market presence457 US product listings · 55 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008943
Lorazepam US-CSAUS-DRUG Not yet graded
Lorlatinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Kinase Inhibitor [EPC]
Earliest US approval2018
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-008946
Losartan Potassium US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]
Earliest US approval1995
Market presence348 US product listings · 46 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008948
Loteprednol Etabonate US-DRUG Not yet graded
US: anda
Class as recordedAminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1998
Market presence44 US product listings · 23 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008949
Lovastatin US-DRUG Not yet graded
US: anda
Class as recordedHMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
Earliest US approval1987
Market presence82 US product listings · 12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008951
Lovotibeglogene Autotemcel US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008952
Low-fat fermented milk with a combination of fructo-oligosaccharides (FOS) and live Lactobacillus rhamnosus GG (ATCC 53103), Streptooccus thermophilus (Z57) and Lactobacillus delbrueckii subsp. bulgaricus (LB2). EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Consumption of low-fat fermented milk with a combination og fructo-oigosaccharides (FPS) and live Lactobacillmus rhamnosus GG (ATCC 53103), Streptococcusd thermopilus (Z57) and Lactobacillus delbruekii subsp. bulgaricus (LB2) helps to reduce recurrence of lip cold sores caused by Herpes simplesx virus infection in helathy susceptible individuals.” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-010741
Lowbush Blueberry US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008953
Loxoprofen US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008955
Loxosceles Reclusa US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antimalarial [EPC]; Ascorbic Acid [CS]; Bee Venoms [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008956
Lozenges with two Lactobacillus reuteri strains: Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289, approximately equal amount of each strain (total minimum amount of 1 × 108 CFU/lozenge of each bacterial strain) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Lozenges containing Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 support normal gum function” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008957
LT toxoid EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008958
Lubabegron Fumarate US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008959
Lubiprostone US-DRUG Not yet graded
US: anda
Class as recordedChloride Channel Activator [EPC]; Chloride Channel Activators [MoA]
Earliest US approval2006
Market presence55 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008960